» Articles » PMID: 7544252

CD5 Expression on B Cells May Be an Activation Marker for Secretion of Anti-myelin Antibodies in Patients with Polyneuropathy Associated with Monoclonal Gammopathy

Overview
Date 1995 Aug 1
PMID 7544252
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

B cells expressing the CD5 marker belong to a subpopulation with potential autoreactive properties. Increased proportions of CD5+ B cells have been reported in autoimmune diseases. In patients with monoclonal gammopathy and demyelinating polyneuropathy, the M-component often consists of autoantibodies reacting with myelin components. We therefore investigated if CD5+ B cells were involved in the production of anti-myelin antibodies. There was no difference of mean value of CD5+ B cells between patients and controls. However, the proportion of CD5+ B cells was significantly correlated with the amount of anti-myelin antibodies. In seven patients, CD5+ B cells were enriched using an immunomagnetic technique. The number of CD5+ and CD5- B cells secreting anti-myelin antibodies was determined by ELISPOT. In two patients with high levels of antibodies, antibody-secreting cells were mainly, but not exclusively, CD5+ B cells. In five patients with low levels of antibodies, most cells secreting anti-myelin antibodies were CD5-. We conclude that CD5 expressed on B cells may be an activation marker, reflecting B cells producing high amounts of anti-myelin antibodies in patients with polyneuropathy associated with monoclonal gammopathy.

Citing Articles

Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS).

Kvarnstrom M, Sidorova E, Nilsson J, Ekerfelt C, Vrethem M, Soderberg O Clin Exp Immunol. 2002; 127(2):255-62.

PMID: 11876747 PMC: 1906329. DOI: 10.1046/j.1365-2249.2002.01739.x.

References
1.
Vrethem M, Skogh T, Berlin G, HOLMGREN H, Ernerudh J . Antibodies to peripheral nerve myelin may occur without clinical neuropathy in healthy persons. J Neuroimmunol. 1991; 32(3):219-22. DOI: 10.1016/0165-5728(91)90191-9. View

2.
Cruz M, Jiang Y, Ernerudh J, Solders G, Olsson T, OSTERMAN P . Antibodies to myelin-associated glycoprotein are found in cerebrospinal fluid in polyneuropathy associated with monoclonal serum IgM. Arch Neurol. 1991; 48(1):66-70. DOI: 10.1001/archneur.1991.00530130076023. View

3.
Vernino L, Pisetsky D, Lipsky P . Analysis of the expression of CD5 by human B cells and correlation with functional activity. Cell Immunol. 1992; 139(1):185-97. DOI: 10.1016/0008-8749(92)90111-2. View

4.
Kantor A . A new nomenclature for B cells. Immunol Today. 1991; 12(11):388. DOI: 10.1016/0167-5699(91)90135-G. View

5.
Kantor A . The development and repertoire of B-1 cells (CD5 B cells). Immunol Today. 1991; 12(11):389-91. DOI: 10.1016/0167-5699(91)90136-H. View